Saving Colombian Healthcare
Saving Colombian Healthcare
in Tags
The Colombian government must look at healthcare as a powerful source of economic growth.
Colombia: Para rescatar el sistema de salud
Colombia: Para rescatar el sistema de salud
in Tags
El presidente Iván Duque prometió, en campaña, aumentar el gasto en salud para hacerle frente a los retos del sistema: envejecimiento poblacional, mayor prevalencia de enfermedades crónicas y persistentes déficits financieros que agravan una deuda acumulada de $8 billones.
Innovation must be embraced as a driver of SA’s economic growth
Innovation must be embraced as a driver of SA’s economic growth
in Tags
As South Africa looks to the future, it can learn from its BRICS partners. China’s focus on innovation, while simultaneously addressing access to medicines, means it is far more in tune with the twenty first century.
La importancia de los Derechos de Propiedad Intelectual para el progreso Una agenda de reformas para los países latinoamericanos
La importancia de los Derechos de Propiedad Intelectual para el progreso Una agenda de reformas para los países latinoamericanos
in
Resumen Con el fin de encontrar nuevas fuentes de crecimiento después de la pandemia de...
Is the OECD ready for Colombian membership?
Is the OECD ready for Colombian membership?
in Tags
The OECD risks weakening its brand by permitting accession of a country that does not fully respect basic market institutions such as intellectual property rights, writes Philip Stevens.
Civil society statement on the EU’s intellectual property incentives review
Civil society statement on the EU’s intellectual property incentives review
in Tags
Following growing concern about the sustainability of healthcare systems, in the summer of 2016 EU Health Ministers invited the European Commission (EC) of the EU to review pharmaceutical innovation incentives.
Delinked from reality
Delinked from reality
in Tags
Replacing patents with prizes to spur drug development is the idea of the moment. But this so-called “delinkage” won’t deliver the innovation and low-cost medicines claimed by its supporters, writes Philip Stevens.
Letter to the European Commission on the review of pharmaceutical innovation incentives
Letter to the European Commission on the review of pharmaceutical innovation incentives
Commissioner Elżbieta BieńkowskaDirectorate-General for Internal Market, Industry, Entrepreneurship and SMEsBuilding BREY1049 BruxellesBelgique 18th December 2017 Dear...
NAFTA and health: how trade improves health
NAFTA and health: how trade improves health
in Tags
Free trade has spread health technologies and knowledge around the world, write Philip Stevens and Nilanjan Banik.